Zydus Life shares rise 5% after strong Q3 earnings
Zydus Lifesciences reported Q3 earnings with revenue up 30.3% to ₹6,865 cr and net profit at ₹1,042 cr, beating estimates. Shares rose 5% on the news, reflecting positive market sentiment.
after close1 source ↓written by the desknot a recommendation
- following its Q3
- 5%
- from ₹5
- ₹6,865 cr
Shares of Zydus Lifesciences gained 5% following its Q3 results, which exceeded expectations. The company's net profit reached ₹1,042 cr, surpassing estimates of ₹940 cr, while revenue surged 30.3% to ₹6,865 cr from ₹5,269 cr last year. This strong performance may enhance investor confidence and support further gains in the stock.
Not investment advice. For informational purposes only.